Huntington’s breakthrough may stop disease

Prof Sarah Tabrizi , from the UCL Institute of Neurology, led the trials By James Gallagher The defect that causes the neurodegenerative disease Huntington’s has been corrected in patients for the first time, the BBC has learned. An experimental drug, injected into spinal fluid, safely lowered levels of toxic proteins in the brain. The researchContinue reading “Huntington’s breakthrough may stop disease”